What Are the Product Recall Classes?

Product recall classes are the three-tier severity system used by the FDA and the Consumer Product Safety Commission to categorize product recalls. Class I means a reasonable probability of serious adverse health consequences or death. Class II means a remote probability of serious harm, or a probability of temporary harm. Class III means a product violates a regulation but is unlikely to cause adverse health consequences. The classification determines recall depth, notification requirements, and regulatory posture.

How the FDA and CPSC Apply the Three Classes

Both agencies use the same Roman numeral system, but the FDA dominates medical device, drug, and food recalls while the CPSC handles consumer products. The FDA issues recall classifications under 21 CFR 7.3 and 21 CFR 810 for medical devices. The CPSC operates under 16 CFR 1115 and the Consumer Product Safety Act.

For a medical device firm, the FDA's classification triggers specific action timelines. A Class I device recall requires the firm to submit a recall strategy within 24 hours of classification. The strategy must name every consignee, describe the health hazard evaluation, and state the depth of recall. Depth means how far down the distribution chain the recall reaches: consumer, retail, or wholesale.

A Class II recall strategy is due within 48 hours. Class III moves at administrative speed, though the firm still files a recall notice and periodic status reports.

The CPSC process differs in one key respect. The CPSC can mandate a recall through a Commission vote if the firm resists voluntary action. FDA lacks direct mandatory recall authority for most devices and drugs, though the FDA Food Safety Modernization Act of 2011 granted mandatory recall power for food. Medical device and drug firms operate under consent decree pressure or voluntary agreement.

What Each Class Means for a Recall Management Practice

Your client, or your own firm if you run a recall management practice, lives in the gap between classification and resolution. The class determines:

• Notification breadth. Class I demands direct consumer notification when the product reached households. Class II may allow wholesale-level correction.
• Press release requirement. The FDA and CPSC both issue public notices for Class I recalls. Class II and III may stay quieter unless the agency judges public interest.
• Escalation path. Class I recalls draw district office investigators, potential for Warning Letter follow-up, and higher probability of consent decree. Class III rarely triggers enforcement beyond the recall close-out.

The classification also sets the recovery economics. A Class I pharmaceutical recall involving a distributed biologic can cost $50 million in logistics alone. A Class III misbranded supplement with limited distribution might cost $200,000. The recall class is the first variable in the engagement scoping conversation.

How Classification Actually Happens

The firm does not self-classify in a vacuum. For FDA-regulated products, the district office or Center for Devices and Radiological Health evaluates the health hazard and assigns the class. The firm submits a recall notification to the FDA, including the proposed classification. The FDA concurs, upgrades, or downgrades.

The health hazard evaluation follows a specific FDA worksheet. It asks: have illnesses or injuries already occurred? Is the condition life-threatening? What is the population at risk? Can the product be easily identified? The answers produce a score that maps to Class I, II, or III.

For CPSC, the firm submits a Section 15(b) report when it learns of a defect. The CPSC staff evaluates the hazard. The firm can propose a voluntary recall. If the CPSC staff disagrees with the firm's classification, the Office of Compliance and Field Operations elevates the matter.

Common Missteps in the Classification Phase

Firms routinely underclassify at submission. A device manufacturer files a recall as Class II because no deaths have occurred, ignoring the FDA's forward-looking standard: reasonable probability of serious harm. The FDA upgrades to Class I, which invalidates the firm's recall strategy, delays the timeline, and signals poor hazard assessment to investigators.

Another error: treating CPSC and FDA classifications as interchangeable. A firm that handles both consumer and medical product recalls needs separate playbooks. The CPSC's fast-track recall program offers reduced publicity in exchange for rapid compliance. The FDA has no equivalent. A firm that applies CPSC logic to an FDA recall misses the notification depth requirements.

The third misstep is failing to update classification as information evolves. A Class II drug recall becomes Class I when post-market adverse event reports show anaphylaxis. The firm must refile the recall strategy and restart the notification clock. Many firms treat the initial classification as fixed.

Where Recall Classes Connect to the Broader Crisis Workflow

The classification sits between detection and execution. Before it: the incident report, the preliminary hazard analysis, the legal hold on documents. After it: the recall strategy, the effectiveness check, the close-out report.

Detection and Initial Assessment

A quality complaint triggers the process. For FDA products, the complaint file lives in 21 CFR 820.198 for devices, 21 CFR 211.198 for drugs. The firm must evaluate within defined timeframes. The CPSC requires Section 15(b) reporting within 24 hours of obtaining information that reasonably supports a defect conclusion.

Health Hazard Evaluation and Classification

The FDA or CPSC assigns the class. The firm may dispute. A dispute adds weeks. Most firms accept the classification and move to strategy.

Recall Strategy and Execution

The strategy names the depth, the notification method, the effectiveness check plan, and the disposition of recalled product. Effectiveness checks verify that consignees received notice and acted. The FDA requires them for Class I and II. Class III may waive them.

Close-Out and Regulatory Follow-Up

The FDA issues a recall termination letter when the agency determines the recall is complete. The CPSC closes the matter through a staff determination. The firm keeps records for the statutory period. Class I recalls draw higher scrutiny in the next inspection.

Related Terms in Crisis and Forensic Recovery

A recall management practice operates at the intersection of regulatory compliance, forensic investigation, and crisis communications. You should also understand Chain of Custody, which governs how recalled product is preserved for liability defense. Root Cause Analysis is the method for determining why the defect occurred, distinct from the recall class which only measures harm probability. Business Interruption quantifies the revenue loss during a recall shutdown. Forensic Engineering provides the technical failure analysis that feeds the health hazard evaluation. Origin and Cause Investigation applies when the recalled product is linked to fire or explosion.

If you run a product recall management firm, your buyers are quality directors, general counsel, and regulatory affairs officers at manufacturers who have never faced a Class I recall and need a partner who has. The product recall management industry page describes how ROI Wire reaches those principals. For more terms in this division, return to the crisis and forensic glossary hub.